Your selections:
- Saul, A., Taylor, B. V., Lechner-Scott, J., van der Mei, I., Blizzard, L., Simpson-Yap, S., Oddy, W. H., Shivappa, N., Hebert, J. R., Black, L. J., Ponsonby, A. L., Broadley, S. A.
- Kuppuswamy, Annapoorna, Billinger, Sandra, Corbett, Dale, Coupland, Kirsten G., English, Coralie, Kutlubaev, Mansur A., Moseley, Lorimer, Pittman, Quentin J., Simpson, Dawn B., Sutherland, Brad A., Wong, Connie
Unchanged cellular inflammatory response following recurrent ST-elevation myocardial infarction
- Lim, Joyce, King, James, Williams, Trent, Boyle, Andrew
A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study
- Saul, Alice M., Taylor, Bruce V., Lechner-Scott, Jeanette, van der Mei, Ingrid, Blizzard, Leigh, Simpson-Yap, Steve, Oddy, Wendy H., Shivappa, Nittin, Hébert, James R., Black, Lucinda J., Ponsonby, Anne-Louise, Broadley, Simon A.
Extracellular matrix protein 1 as a mediator of inflammation-to-fibrosis progression after myocardial infarction
- Hardy, Sean A., Liesinger, Laura, Murtha, Lucy A., Starkey, Malcolm R., Scherr, Daniel, Hansbro, Philip M., Hoefler, Gerald, Campos Ramos, Gustavo, Cochain, Clement, Harvey, Richard P., Birner-Gruenberger, Ruth, Boyle, Andrew J., Patrick, Ralph, Rainer, Peter P., Poettler, Maria, Rech, Lavinia, Gindlhuber, Juergen, Mabotuwana, Nishani S., Ashour, DiyaaEldin, Stangl, Verena, Bigland, Mark
Inflammatory cell response following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention and its impact on cardiovascular outcomes: A systematic review and meta-analysis
- Lim, Joyce, Davies, Allan, Brienesse, Stephen, Mabotuwana, Nishani S., Boyle, Andrew
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
- Xavier, Alexandre, Campagna, Maria Pia, Lechner-Scott, Jeannette, Ausimmune Investigator Group,, Maltby, Vicki E., Kilpatrick, Trevor, Taylor, Bruce V., Butzkueven, Helmut, Ponsonby, Anne-Louise, Scott, Rodney J., Jokubaitis, Vilija G., Lea, Rodney A.
Is it ethical to use teriflunomide as an active comparator in phase 3 trials?
- Giovannoni, Gavin, Hawkes, Christopher H., Lechner-Scott, Jeannette, Levy, Michael, Yeh, E. Ann
- Phung, Jason, Wang, Carol, Reeders, Jocelyn, Zakar, Tamas, Paul, Jonathan W., Tyagi, Sonika, Pennell, Craig E., Smith, Roger
- Ramsahai, J. Michael, Simpson, Jodie L., Cook, Alistair, Gibson, Peter G., McDonald, Vanessa, Grainge, Christopher, Heaney, Liam G., Wark, Peter A. B.
- Clarke, Erin D., Stanford, Jordan, Ferguson, Jessica J. A., Wood, Lisa G., Collins, Clare E.
- Ajgaonkar, Sandeep, Hirst, Jonathan J., Norris, Mary, Zakar, Tamas
- Negewo, Netsanet A., Gibson, Peter G., Simpson, Jodie L., McDonald, Vanessa M., Baines, Katherine J.
Soluble fibre as an anti-inflammatory treatment in asthma
The role of the blood-brain barrier during neurological disease and infection
- Patabendige, Adjanie, Janigro, Damir
- Mandelli, Laura, Milaneschi, Yuri, Hiles, Sarah, Serretti, Alessandro, Penninx, Brenda W.
Adiposity associated DNA methylation signatures in adolescents are related to leptin and perinatal factors
- Huang, R. C., Melton, P. E., Rauschert, S., Craig, J. M., Kobor, M. S., MacIsaac, J. L., Morin, A. M., Oddy, W. H., Pennell, C. E., Holbrook, J. D., Lillycrop, K. A., Burton, M. A., Beilin, L. J., Clarke-Harris, R., Cook, E., Godfrey, K. M., Burdge, G. C., Mori, T. A., Anderson, D.
Alterations in brainstem respiratory centers following peripheral inflammation: A systematic review
- Hedley, Kateleen E., Callister, Robert J., Callister, Robin, Horvat, Jay C., Tadros, Melissa A.
- Ahmed Nasef, Noha, Thota, Rohith N., Mutukumira, Anthony N., Rutherfurd-Markwick, Kay, Dickens, Martin, Gopal, Pramod, Singh, Harjinder, Garg, Manohar L.
Are you sure you would like to clear your session, including search history and login status?